AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca commingled target-date & index funds ($) ($)
Form 11-K Fair Value Hierarchy Note
Latest, FY2025
6,944,172,080
Period ended Dec 31, 2025
Change on a year earlier
+17.9%
5,889,523,103 in FY2024
History
4 years
Since FY2022
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Commingled target-date & index funds ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6,944,172,080 | +17.9% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 5,889,523,103 | +16.8% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 5,040,438,572 | +34.5% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | 3,748,004,997 | – | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca Commingled target-date & index funds ($) ($), annual FY2022–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_fv_commingled
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.